Pacira BioSciences Inc (PCRX)
26.26
+0.21
(+0.81%)
USD |
NASDAQ |
Apr 30, 16:00
26.26
0.00 (0.00%)
After-Hours: 16:00
Pacira BioSciences Cash from Investing (Quarterly): 8.374M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.374M |
| September 30, 2023 | -4.342M |
| June 30, 2023 | 7.326M |
| March 31, 2023 | 66.18M |
| December 31, 2022 | 11.19M |
| September 30, 2022 | -47.52M |
| June 30, 2022 | 19.16M |
| March 31, 2022 | -208.02M |
| December 31, 2021 | 66.92M |
| September 30, 2021 | -35.08M |
| June 30, 2021 | 3.033M |
| March 31, 2021 | -55.66M |
| December 31, 2020 | -82.32M |
| September 30, 2020 | -202.85M |
| June 30, 2020 | 36.12M |
| March 31, 2020 | -28.57M |
| December 31, 2019 | -30.80M |
| September 30, 2019 | 5.625M |
| June 30, 2019 | -181.80M |
| March 31, 2019 | 78.48M |
| December 31, 2018 | -123.16M |
| September 30, 2018 | 94.46M |
| June 30, 2018 | 59.57M |
| March 31, 2018 | -10.29M |
| December 31, 2017 | 8.699M |
| Date | Value |
|---|---|
| September 30, 2017 | -27.48M |
| June 30, 2017 | -61.15M |
| March 31, 2017 | -143.84M |
| December 31, 2016 | -6.917M |
| September 30, 2016 | -13.32M |
| June 30, 2016 | -19.64M |
| March 31, 2016 | -21.88M |
| December 31, 2015 | 7.296M |
| September 30, 2015 | -8.742M |
| June 30, 2015 | -18.01M |
| March 31, 2015 | 0.20M |
| December 31, 2014 | 2.306M |
| September 30, 2014 | -101.18M |
| June 30, 2014 | -30.57M |
| March 31, 2014 | 9.019M |
| December 31, 2013 | 15.22M |
| September 30, 2013 | 3.615M |
| June 30, 2013 | -5.523M |
| March 31, 2013 | -56.25M |
| December 31, 2012 | 22.36M |
| September 30, 2012 | -1.809M |
| June 30, 2012 | -47.54M |
| March 31, 2012 | -2.53M |
| December 31, 2011 | -11.77M |
| September 30, 2011 | -2.565M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-208.02M
Minimum
Mar 2022
66.92M
Maximum
Dec 2021
-34.37M
Average
-4.342M
Median
Sep 2023
Cash from Investing (Quarterly) Benchmarks
| Dynavax Technologies Corp | -20.24M |
| Arbutus Biopharma Corp | 22.22M |
| Chimerix Inc | 28.07M |
| Karyopharm Therapeutics Inc | 26.84M |
| FibroGen Inc | 10.24M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 47.58M |
| Cash from Financing (Quarterly) | -1.779M |
| Free Cash Flow | 139.49M |
| Free Cash Flow Per Share (Quarterly) | 0.6647 |
| Free Cash Flow to Equity (Quarterly) | 47.93M |
| Free Cash Flow to Firm (Quarterly) | 45.79M |
| Free Cash Flow Yield | 9.70% |